Ushbu ish iqtibos qilgan ishlar

76 ta ish

Ish: Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation

1. Antimycobacterial Eudesmanolides from Inula helenium and Rudbeckia subtomentosa

   Charles L. Cantrell, Laura Abate, Frank R. Fronczek +3

   Maqola19994 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.313743

2. Breast cancer: pathogenesis and treatments

   Xin Xiong, Lewei Zheng, Yu‐Qiang Ding +7

   Sharh maqola20253 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.311722

3. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

   Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

   MaqolaPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.075060

4. A comprehensive review of anticancer mechanisms of action of Alantolactone

   Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Masoumeh Rajabi Bazl +1

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.107404

5. Alantolactone inhibits cervical cancer progression by downregulating BMI1

   Xiaodong Sun, Hongxia Xu, Tianyu Dai +7

   Maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.149099

6. Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones

   Ana Paço, Teresa Brás, Jacqueline Oliveira dos Santos +3

   Sharh maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.291057

7. What made sesquiterpene lactones reach cancer clinical trials?

   Akram Ghantous, Hala Gali‐Muhtasib, Heikki Vuorela +2

   Sharh maqola20102 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.313752

8. Alantolactone induces apoptosis and suppresses migration in MCF‑7 human breast cancer cells via the p38�MAPK, NF‑κB and Nrf2 signaling pathways

   Jianli Liu, Meijia Liu, Shuai Wang +4

   Maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.313774

9. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.313741

10. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313742

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313744

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313745

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313746

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313747

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313748

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313749

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313750

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313751

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313753

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313754

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313755

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313756

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313757

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313758

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.313759